|Research your Stock | Technical Calls | Live Market Action | Archives | Join Xchange|
Welcome to Market Insights.
This week we have ShareTipsInfo analyzing PTC India Financial Services. With strong growth prospects of the company, investors are recommended to buy. HDFC Securities provide analyses on Nifty and choose Sun Pharma as their weekly momentum pick. Investors are recommended to buy Sun Pharma with a price target of 950-970. Smitha Hari, reviews LIC's Jeevan Arogya Health Plan. Lastly, Bank Bazaar provide some important suggestions for healthy asset allocation.
Do you like reading our newsletter? Drop in your comments.
|Weekly Nifty: Overall positive bias continues|
|Overall positive bias is continuing in the market, buy the strong stocks and don’t do bottom fishing. Traders can continue with the long positions with the stop of 8265 for target of 8550/8600 levels.|
|Weekly Pick: Buy Sun Pharma between CMP and Rs860|
|The stock is showing positive bias for the short term. HDFC Securities recommend investors to buy Sun Pharma between CMP and Rs860 for price targets of Rs950-970 and with a stop loss placed at Rs835 in 7-30 days.|
|Review of LIC's Health Plan - Jeevan Arogya|
|The Jeevan Arogya plan of LIC offers health protection to the policy holder, which offers various benefits. Although the premium is competitive, the maximum sum assured option is limited, and there are some restrictions on the number of times one can claim various benefits.|
|Tips for a healthy asset allocation|
|Choosing the right investment vehicles for one’s investment portfolio is known as asset allocation. One of the easiest ways to understand asset allocation is to consider it as a financial strategy by diversifying the overall investment into various investment categories like stocks, bonds, fixed deposits, real estate etc.|
|Today's Technical Call by Dharmesh Bhatt
Shriram Transport & Adani Ports: Huge upmove on the cards. Grab Futures
|Get day to day calls and stock tips with our Technical Newsletter section - Follow this page on LinkedIn here|
|Advertise with us | Write for us | Blog on Xchange | Archives | Feedback|